文献速递鼻科

黏膜嗜酸性粒细胞计数指导慢性鼻窦炎治疗

Use of mucosal eosinophil count as a guide in the management of chronic rhinosinusitis.
PubMed 文献 · Int Forum Allergy Rhinol · 2020-01-12

本研究回顾性分析2004至2017年接受功能性内镜鼻窦手术的156例慢性鼻窦炎患者,评估黏膜嗜酸性粒细胞计数(MEC)在术后医疗管理中的指导作用。结果显示MEC与客观疾病严重程度相关,MEC越高,需要升级药物治疗和修正手术的风险显著增加。

要点

  • MEC与术后6个月和1年鼻内镜评分及术前CT评分良好相关。
  • MEC每增加1个/HPF,需2联、3联药物及修正手术的比值比分别为1.1、1.12、1.11。
  • MEC或可作为个体化治疗强度的参考指标。

核心结论

  • MEC与客观临床疾病严重程度相关,可能指导个体化治疗的积极程度。

研究设计与样本

  • 回顾性研究,纳入2004至2017年接受FESS的156例CRS患者,组织MEC由病理检查确定。

主要发现

  • 术后6个月和1年SNOT-22(18.1±17.0、18.1±20.2)及鼻内镜评分(3.6±3.8、3.6±4.1)均显著低于术前(37.4±22.8、6.5±4)。
  • MEC增加时,需2联治疗(OR=1.1,p=0.0002)、3联治疗(OR=1.12,p<0.0001)和修正手术(OR=1.11,p<0.0001)的比值比显著增加。
  • 术前鼻内镜评分(ρ=0.44,p<0.0001)、CT评分(ρ=0.51,p<0.0001)及术后6个月(ρ=0.55,p<0.0001)和1年(ρ=0.4,p<0.0001)鼻内镜评分与MEC良好相关。

临床怎么用

  • 可根据MEC评估CRS术后疾病严重程度,辅助决定药物治疗强度和是否需修正手术。

局限性

  • 回顾性设计可能引入选择偏倚,单中心数据需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic rhinosinusitis (CRS) is a local inflammatory process driven by eosinophils. Mucosal eosinophil count (MEC) has previously been demonstrated to be a reliable indicator of disease severity. We aim to evaluate use of MEC in guiding medical management of CRS after functional endoscopic sinus surgery (FESS). METHODS: We retrospectively reviewed patients with CRS who underwent FESS from 2004 to 2017. Tissue MEC per high-power field (HPF) was determined by pathologic examination. MECs were compared by polyp status, postoperative medication requirements, and revision surgery. Patients received normal saline (NS) nasal irrigations with additional treatment as needed for disease control: 1-drug therapy (1-DT) intranasal steroid spray (ISS), 2-drug therapy (2-DT) ISS plus budesonide nasal irrigations (BNI) or leukotriene receptor antagonist (LRA), or 3-drug therapy (3-DT) ISS plus BNI and LRA. Correlations between MEC and 22-item Sino-Nasal Outcome Test (SNOT-22), preoperative computed tomography (CT), and nasal endoscopy scores were evaluated. RESULTS: A total of 156 patients were included. Fifty-seven were managed with 1-DT, 35 with 2-DT, and 62 with 3-DT. Across all patients, mean postoperative 6-month and 1-year SNOT-22 (18.1 ± 17.0, 18.1 ± 20.2, respectively) and nasal endoscopy (3.6 ± 3.8, 3.6 ± 4.1, respectively) scores were significantly lower than preoperative scores (37.4 ± 22.8, 6.5 ± 4, respectively). With increasing MEC, odds of requiring 2-DT (odds ratio [OR] = 1.1, p = 0.0002), 3-DT (OR = 1.12, p < 0.0001), and revision surgery (OR = 1.11, p < 0.0001) were significantly increased. Preoperative endoscopy (ρ = 0.44, p < 0.0001) and CT scores (ρ = 0.51, p < 0.0001) and postoperative 6-month (ρ = 0.55, p < 0.0001) and 1-year (ρ = 0.4, p < 0.0001) endoscopy scores demonstrated good correlation with MEC. CONCLUSION: MEC correlates with objective clinical disease severity and may guide aggressiveness of management for the individual patient.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Sharbel D, Li M, Unsal AA, et al. Use of mucosal eosinophil count as a guide in the management of chronic rhinosinusitis. Int Forum Allergy Rhinol. 2020. PMID: 31930720. doi:10.1002/alr.22517

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。